Vyome Therapeutics Achieves Positive Results in Phase 2 Trial of VB-1953

Catawba Research is proud to have served as the CRO for Vyome Therapeutics on their successful Phase 2 Trial of VB-1953 for Moderate to Severe Acne. Needless to say, Catawba Research is excited for our client and honored to be by their side. Vyome Therapeutics is a clinical-stage company developing locally-acting, next generation therapeutics for…